Title(s): Prof. Dr.
Current Position/Designation: Head of Pediatric Neurology,
Institutional Affiliation: Children’s Hospital Datteln, University Witten/Herdecke, Germany, Dr. Friedrich Steiner Str. 5, D-45711 Datteln, GERMANY.
Active Email Address: K.Rostasy@kinderklinik-datteln.de
Telephone Number (WhatsApp): +4915773974970
President of the European Paediatric Neurology Society (EPNS)
Professor of Paediatric Neurology
Head of Paediatric Neurology, Witten/Herdecke University, Children’s Hospital Datteln, GERMANY.
2014- Head of Pediatric Neurology, Children’ Hospital Datteln, University Witten/Herdecke, Germany, 2007-2014 Head of Pediatric Neurology, Medical University Innsbruck, Austria), 2001-2007 Pediatric Neurologist, Department of Pediatrics, Medical University, Göttingen, Germany. 2006 Habilitation/PhD, Medical University Göttingen, „Inflammation and neuroaxonal injury in MS and AIDS dementia complex”. 1999-2001 NIH Research Fellow “Molecular and cellular mechanisms of cerebral injury in the AIDS”. 1996-1999 Neuropediatric Residency Program (Floating Hospital for Children, Boston, USA). 1991-1996 MRCP I/II (Member Royal College of Physicians): Edinburgh, Scotland and Senior- and Supervisory-Senior-House-Officer/ Royal Aberdeen Children’s Hospital, Scotland.
Since 2007 I am running large Departments of Pediatric Neurology involving all aspects of this discipline including also the spectrum of neurorehablitation and palliative care.
2022 I was elected President of one of the largest organisations of Pediatric Neurology the “EPNS” with a strong focus on advocacy addressing in particular the needs of children with neurological disorders in collaboration with other stakeholders such as the WHO, EBS and others.
Long-term member of different professional organization such as the IPMSSG, EPNS and GNP with different positions over the years including serving as board members and/president influencing the development and shaping the current state of the different pediatric neurology associations. In addition the contributions of my team together with many collaborators in the field of pediatric neuroimmunology led to the clinical characterization of several new antibody-mediated disease such as MOGAD and subsequntely to a better understanding and treatment options.